Women's Health News

RSS

Researchers suggest 'watch and wait' strategy for girls with germ-cell ovarian tumors

Researchers from Dana-Farber/Children's Hospital Cancer Center (DF/CHCC) have found that as many as 50 percent of young girls treated for germ-cell ovarian tumors might safely be spared chemotherapy using a "watch and wait" strategy to determine if the follow-up treatment is needed.

21 Oct 2010

Hormone therapy increases breast cancer mortality risk, study finds

Hormone treatment after menopause, already known to increase the risk of breast cancer, also makes it more likely that the cancer will be advanced and deadly, a study finds.

21 Oct 2010

Menopausal estrogen replacement therapy speeds growth of ovarian cancer

Estrogen therapy used by menopausal women causes a type of ovarian cancer to grow five times faster, according to a new study by researchers at the University of Colorado Cancer Center.

21 Oct 2010

Also in Global Health News: Foreign aid in Ethiopia; Elizabeth Glaser Pediatric AIDS Foundation; Health in Myanmar; Poverty in Zambia; Rwanda's progress on MDGs; Men involved in PMTCT of HIV

Ethiopia's government has been restricting access to food and other types of foreign aid among opposition supporters, Human Rights Watch (HRW) said in a report on Tuesday, Reuters reports (Malone, 10/19). The report is based on more than 200 interviews, conducted over a six-month period in 2009, of people in 53 villages across three regions of the country, according to an HRW press release (10/19).

21 Oct 2010

Overweight dads may pass on diabetes to their daughters: Study

According to a latest study fathers on a high-fat diet are more likely to produce daughters with a higher diabetes risk. The study was published in the journal Nature and it involved laboratory rats.

20 Oct 2010

CRN reinforces importance of DHA before, during and after pregnancy

In response to a study regarding fish oil use during pregnancy published in the October 19 issue of the Journal of the American Medical Association (JAMA), the Council for Responsible Nutrition (CRN), the leading trade association for the dietary supplement industry, reminds pregnant and lactating women of the undisputed importance of consuming the recommended amounts of docosahexaenoic acid (DHA) throughout pregnancy.

20 Oct 2010

More education and attention needed on inflammatory breast cancer

Inflammatory breast cancer (IBC), an aggressive and rare malignancy, is often initially misdiagnosed as an infection or rash. However, getting the correct diagnosis quickly is critical for patients because the disease spreads beyond the breast in a matter of just days or weeks.

20 Oct 2010

New report focuses on inflammatory breast cancer

A rare and deadly form of breast cancer that often goes unrecognized by clinicians and patients alike is the focus of a new report from leading researchers. Inflammatory breast cancer (IBC) has made headlines as an unrecognized and misunderstood form of breast cancer. It has a younger age of onset, progresses rapidly, and has lower overall survival compared to other breast cancers.

20 Oct 2010

National Pap Test Campaign for cervical cancer diagnosis

The Federation of Medical Women of Canada (FMWC) and the Society of Obstetricians and Gynaecologists of Canada (SOGC) are ready to launch this year's National Pap Test Campaign, to take place during National Cervical Cancer Awareness Week. From October 24th to 30th, over 100 health-care professionals across Canada are taking a stand against cervical cancer by hosting public Pap test clinics in their community.

20 Oct 2010

UTHSC-Houston initiates enrollment in NanoLogix technology trial for detection of GBS in pregnant women

NanoLogix, an innovator in the accelerated detection and identification of microorganisms, announced today that the University of Texas Health Science Center in Houston is enrolling 300 patients in an ongoing clinical trial to study the speed and accuracy of NanoLogix technology. The trial is designed to compare NanoLogix technology to current methods in use for detection and identification of Group B Streptococcus (GBS) in pregnant women.

20 Oct 2010

Consumption of fish oil capsules during pregnancy does not reduce post-natal depression

A University of Adelaide study has found no evidence that taking fish oil capsules during pregnancy can help reduce the risk of post-natal depression, contrary to international recommendations.

20 Oct 2010

NIH awards 5-year, $3.7M grant for study of intrauterine cocaine and substance exposure

Deborah A. Frank, MD, the Director of the Grow Clinic for Children at Boston Medical Center (BMC) and a Professor of Pediatrics at Boston University School of Medicine (BUSM), has received a 5-year, $3.7 million grant from the National Institutes of Health to study the long-term impacts of intrauterine cocaine exposure (IUCE) and intrauterine substance exposure (IUSE).

20 Oct 2010

AU launches African women's decade project to improve health, development

Delegates from around the world attended the launch of the African Women's Decade, 2010-2020, (AWD) at an event in Nairobi, Kenya, on Friday, the Kenya Broadcasting Corporation reports.

20 Oct 2010

Fish oil not as good for pregnant mums as thought: Study

According to a new Australian study, taking fish oil / docosahexaenoic acid (DHA) supplements during pregnancy does not appear to reduce the risk of postpartum depression of mothers or boost the language development and cognitive skills of their children.

19 Oct 2010

Agendia establishes contract with Humana for coverage of MammaPrint breast cancer recurrence test

Agendia, a world leader in molecular cancer diagnostics, announced today that it has established a contract with leading insurance provider Humana to reimburse for the company's MammaPrint test. Agendia's contract with Humana expands the coverage for MammaPrint by more than 17 million lives. In November 2009, Palmetto GBA, California's Part B Medicare administrator, established coding guidelines for MammaPrint, allowing healthcare providers from across the United States to submit claims for the test.

19 Oct 2010

Syneron launches VelaBABE device for women to reclaim pre-baby body

Syneron Medical Ltd., a leading medical aesthetic device innovator, is announcing their new VelaBABE promotion for women who want to reclaim their pre-baby body with help from VelaShape.

19 Oct 2010

Fatalism may prevent Latinas from using cancer screening services

Fatalism may prevent women from Latin American descent Latinas from using cancer screening services, according to Karla Espinosa de los Monteros and Dr. Linda Gallo from San Diego State University in the US. Their review shows that women who are pessimistic about preventive health practices and disease outcomes are less likely to have been screened for cervical, breast and colorectal cancer. The research is published online in Springer's International Journal of Behavioral Medicine.

19 Oct 2010

Study: Women's labor experience tied to ethnicity and genetics

Results from a clinical study presented at ANESTHESIOLOGY 2010 suggest that a women's labor experience is tied to her ethnicity as well as genetics.

19 Oct 2010

Novartis announces six-year data of Reclast injection for postmenopausal women with osteoporosis

Novartis announced today that new six-year data reinforce the long-term efficacy and safety profile of once-yearly Reclast (zoledronic acid) injection in postmenopausal women with osteoporosis.The study of more than 1,200 women was presented this weekend at the annual meeting of the American Society for Bone and Mineral Research (ASBMR) in Toronto, ON, Canada.

19 Oct 2010

New data on Merck’s odanacatib for osteoporosis in postmenopausal women presented at 32nd ASBMR

New data on odanacatib, an investigational cathepsin-K (Cat-K) inhibitor in development for the treatment of osteoporosis in postmenopausal women, were presented at the 32nd Annual Meeting of the American Society for Bone and Mineral Research (ASBMR) in Toronto, Canada.

19 Oct 2010

Women's Health News

Researchers suggest 'watch and wait' strategy for girls with germ-cell ovarian tumors

Hormone therapy increases breast cancer mortality risk, study finds

Menopausal estrogen replacement therapy speeds growth of ovarian cancer

Also in Global Health News: Foreign aid in Ethiopia; Elizabeth Glaser Pediatric AIDS Foundation; Health in Myanmar; Poverty in Zambia; Rwanda's progress on MDGs; Men involved in PMTCT of HIV

Overweight dads may pass on diabetes to their daughters: Study

CRN reinforces importance of DHA before, during and after pregnancy

More education and attention needed on inflammatory breast cancer

New report focuses on inflammatory breast cancer

National Pap Test Campaign for cervical cancer diagnosis

UTHSC-Houston initiates enrollment in NanoLogix technology trial for detection of GBS in pregnant women

Consumption of fish oil capsules during pregnancy does not reduce post-natal depression

NIH awards 5-year, $3.7M grant for study of intrauterine cocaine and substance exposure

AU launches African women's decade project to improve health, development

Fish oil not as good for pregnant mums as thought: Study

Agendia establishes contract with Humana for coverage of MammaPrint breast cancer recurrence test

Syneron launches VelaBABE device for women to reclaim pre-baby body

Fatalism may prevent Latinas from using cancer screening services

Study: Women's labor experience tied to ethnicity and genetics

Novartis announces six-year data of Reclast injection for postmenopausal women with osteoporosis

New data on Merck’s odanacatib for osteoporosis in postmenopausal women presented at 32nd ASBMR

Sensing a Healthier Future

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Latest News